baber/WOPTO huggingface dataset:
Patent JP-4248626-B2 (JP)
IPC: H02K5/128
Filed: 1998-07-22
Granted: 2009-04-02
Abstract: An implantable rotary sealless blood pump (11) is provided. The pump (11) includes a housing (12) having an inlet tube (13) on one end and an impeller casing (14) on the other end. A rotor (17) is mounted for rotation within the housing (12), with the rotor (17) having an elongated shaft portion (18) and an impeller (19) attached to the shaft portion (18). The impeller (19) is located within the impeller casing (14). Radial magnetic bearings (28,29) are carried by the shaft portion (18) and radial magnetic bearings (23,24) are carried by the housing (12) for maintaining the shaft portion (18) of the rotor (17) within the inlet tube (13) of the housing (12). A rotor motor (53) includes a plurality of permanent magnets (54) carried by the impeller (19) and a motor stator (56) including an electrically conductive coil (57) located within the housing (12). A ring of back iron (58) is carried by the impeller casing (14) to aid in completing a flux return path for the permanent magnets (54). A plurality of hydrodynamic thrust bearings are located outside of the axis of rotation of the rotor (17). The impeller (19) uses large axially thick blade sectors (49) with narrow blood channels (51) extending through the impeller (19), to minimize hemolysis and to increase the working surface of the blades (49). <IMAGE>
Patent JP-3053413-B2 (JP)
IPC: C07D413/14
Filed: 1990-08-17
Granted: 2000-06-19
Abstract: Carboxylic acid derivatives of the general formula I   <IMAGE> I where R1 and R2 are each C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy and/or C1-C4-alkylthio; R3 is hydrogen, hydroxyl, cyano, nitro, formyl, halogen, unsubstituted or substituted amino, C1-C4-alkyl, C1-C4-alkoxy, C3-C6-alkenyl, C3-C6-alkenyloxy, C3-C6-alkynyl or C3-C6-alkynyloxy; R4 is hydrogen or C1-C4-alkyl; R5 is unsubstituted or substituted five-membered hetaryl or isoxazolinyl or -CR6=NOR7; R6 is hydrogen or unsubstituted or substituted C1-C4-alkyl, C3-C8-cycloalkyl or phenyl; R7 is unsubstituted or substituted C1-C4-alkyl, C3-C6-alkenyl, C3-C8-cycloalkyl or phenyl; A is oxygen or sulfur; X is nitrogen or methine =CR8-; R8 is one of the radicals R3, or R8 and R3 together form unsubstituted or substituted 1,3-butadiene-1,4-yl or aza-1,3-butadiene-1,4-yl, and Y and Z are each nitrogen or methine =CH-, their preparation and agents containing them.
Patent JP-2642047-B2 (JP)
IPC: A61B19/00
Filed: 1993-10-04
Granted: 1997-08-20
Abstract: An apparatus used to assist a surgeon in surgery is divided into two parts, proximal and distal. The apparatus has a number of rigid links (1 - 4) which rotate about pivots (A - L) to position and re-position an instrument (11), like a surgical instrument, at a work point (Cmot) proximal to a patient but remote from the apparatus. The links cooperate in a way to move the manipulator about a center-of-motion (Cmot) with orthogonally decoupled degrees of freedom resolved at the work point. The proximal part (26) of the apparatus is adjustably fixed to a stationary object, like an operating table (22), while the distal part (25) of the apparatus holds the instrument (11). Certain links which can be adjusted in length, move the distal part with respect to the proximal part of the apparatus. In this manner, the work point of the manipulator and the working radius of the apparatus are changed without moving the proximal part. Actuators, manual or remotely (computer) controlled, both rotate the links about their pivots and adjust the length of the adjustable links. All the actuators can be mounted on the proximal part of the apparatus and electrically isolated from the manipulator in order to reduce the shock hazard to the patient. <IMAGE>
Patent JP-2938450-B2 (JP)
IPC: H01R13/6581
Filed: 1986-11-12
Granted: 1999-08-23
Abstract: A shielded connector for electrical circuits comprising a non-conducting housing containing electrically conductive terminals and an electrically conductive housing, said electrically conductive housing comprising at least two elements, each of said elements being capable of mating with the other of said elements, at least one of said elements having at least one recessed pocket having an aperture open to the exterior of said element, each of said pockets being adapted to hold a projection on a latch, the interior walls of said pocket being continuous with the exterior walls of said electrically conductive housing and either a portion of said pocket also being located in a second element or at least one wall of said pocket being contributed by a second element.
Patent JP-H0647750-B2 (JP)
IPC: C25D5/28
Filed: 1988-10-26
Abstract: An apparatus for the galvanic reinforcement of an automotive trace on a glass pane, especially a motor vehicle glass pane, has an elongated housing adapted to enclose the trace and spaced uniformly from opposite longitudinal edges thereof. The electrolyte and a rinsing liquid can be passed uniformly through this chamber within which a anode extends in juxtaposition with the trace which is poled as a cathode. Between the anode and the cathode an electrodeposition current is passed to deposit metal from the electrolyte onto the trace.
Patent JP-3157879-B2 (JP)
IPC: B05B11/00
Filed: 1991-11-06
Granted: 2001-04-16
Abstract: In a dispensing device (1), the return spring (21) of a return element (20) for a discharge pump (7) and for valves (26, 30) is located separated from the fluid in a tightly sealed spring chamber (22). The fluid inlet opening (31) into the discharge pump (7) is located eccentrically with respect to the latter and opens into an external, annular pre-intake chamber (15) from which the fluid passes via an intermediate valve (30) into the pump chamber (39). As a result, contact of the fluid with metallic parts is avoided and both favourable flow paths for the fluid and a compact design of the pump are obtained. <IMAGE>
Patent JP-2798455-B2 (JP)
IPC: C08F2/22
Filed: 1989-12-25
Granted: 1998-09-17
Abstract: Aqueous polymer dispersions containing latex particles having a mean particle diameter of less than 140 nm comprise a) from 5 to 45 % by weight of a core material having a dynamic glass transition temperature of greater than 60 degrees C and b) from 95 to 55 % by weight of a shell material having a dynamic glass transition temperature of below 80 degrees C, the dynamic glass transition temperature of the shell being at least 20 K below that of the core, have a low minimum film-formation temperature and give films of low tack and high blocking point.
Patent JP-2726647-B2 (JP)
IPC: A61K38/00
Filed: 1995-12-28
Granted: 1998-03-11
Abstract: Disclosed are (1) a cyclic hexapeptide represented by formula [I] or a salt thereof: <CHEM> wherein X and Y each represent  alpha -amino acid residues, A represents a D-acidic- alpha -amino acid residue, B represents a neutral- alpha -amino acid residue, C represents an L- alpha -amino acid residue and D represents a D- alpha -amino acid residue having an aromatic ring group; and (2) a pharmaceutical composition comprising the peptide represented by formula [I] or a pharmaceutically acceptable salt thereof as an active ingredient.
Patent JP-3208697-B2 (JP)
IPC: G01P15/08
Filed: 1993-12-28
Granted: 2001-09-17
Abstract: PURPOSE:To make it possible to apply the cornering lamp system to all models without its correspondence-relation to the illuminating angle, and in the same system-construction, and ensure the field of view in the advancing direction without generating unnatural action when a vehicle is right- or left-turned. CONSTITUTION:The angular velocity omeganew at the time when a vehicle 7 06 travels on a curved road, is calculated based on output from an angular velocity sensor (step 101). The car speed is measured based on the distance pulse from a distance sensor (step 102). The angular velocity omeganew is divided by the car speed (v) to calculate the reciprocal of a turning radius (r), and a target value thetas of the illuminating angle is determined by multiplying the reciprocal of the turning radius (r) by a constant K (step 110). At this time, for example, when a vehicle is stopped at an intersection and a right winker is operated (step 107), the target value thetas reaches a maximum in the right direction (step 116).
Patent JP-3135536-B2 (JP)
IPC: A61K8/22
Filed: 1998-12-15
Granted: 2001-02-19
Abstract: Hair dye compositions containing pyrazolo-azole compounds of formula (I) as oxidation base. Composition for oxidation dyeing of keratinic fibers, especially human hair comprises at least one pyrazolo-azole compound of formula (I) and/or its acid addition salt in a suitable medium: R<1> = H; 1-20C alkyl, aryl (such as phenyl or naphthyl) or a 5- or 6-membered heterocyclic group containing at least one N, O or S (such as pyridyl, quinolyl, pyrrolyl, morpholinyl, furanyl, tetrahydrofuranyl, pyrazolyl, triazolyl, tetrazolyl, thiazolyl, oxazolyl, imidazolyl or thiadiazolyl) each optionally substituted by 1 or 2 R; if R<1> = 1-4 C alkyl or a 5- or 6-membered heterocycle then it may bound to the C atom of the pyrazole ring by way of an intermediate -O-, -NH- or -S- group; R<1> may also be halo (Br, Cl or F); acyl; sulfonyl; sulfinyl; phosphonyl; carbamoyl; sulfamoyl; CN; siloxy; NH2; acylamino; acyloxy; carbamoyloxy; sulfonamido; imido; ureido; sulfamoylamino; alkoxy(C1-C4)carbonylamino; aryloxycarbonylamino; alkoxy(C1-C4)carbonyl; aryloxycarbonyl; carboxyl or OH; R = halo, NO2, CN, OH, alkoxy, aryloxy, NH2, alkylamino, acylamino, carbamoyl, sulfonamido, sulfamoyl, imido, alkylthio, arylthio, aryl (such as phenyl or naphthyl), alkoxy-1-4C carbonyl or acyl; R<2> = H; 1-4C alkyl; 1-4C monohydroxyalkyl; 2-4C polyhydroxy; 1-4C aminoalkyl; -(CH2)p-X-(CH2)qOR'; alkoxy-1-4C alkyl with 2-4 C; or di-alkyl-1-4C aminoalkyl with 1-4C; Za-Zc = -N-, -C(R<3>)- or -C(R<4>)- ; R3, R4 = as R1; or R<3> + R<4> = optionally substituted aryl group such as phenyl; p = 1-3; R', R'' = H or Me; X = O or NR''. provided that at least one of Za-Zc is other than a C atom; Independent claims are included covering: (1) a procedure for dyeing hair using a dye composition including an oxidation base (I); and (2) a hair dyeing kit having one compartment containing a tinctoral composition as claimed and a second compartment containing an oxidizing agent which is mixed in when required for use.
Patent JP-2710470-B2 (JP)
IPC: C12R1/865
Filed: 1990-12-05
Granted: 1998-02-10
Abstract: Mutant transformed fungal (eg yeast) strains producing high levels of heterologous protein may be detected by plating fungal cells onto a solid medium such as agarose and applying antibodies to the heterologous protein. The resulting complexes can either be visualised directly or following staining or labelling.
Patent JP-H0796496-B2 (JP)
IPC: A23G4/04
Filed: 1985-12-21
Abstract: PCT No. PCT/EP85/00735 Sec. 371 Date Aug. 26, 1986 Sec. 102(e) Date Aug. 26, 1986 PCT Filed Dec. 21, 1985 PCT Pub. No. WO86/03967 PCT Pub. Date Jul. 17, 1986.A chewing gum which consists of a chewing gum base, fats or waxes, fillers, additives and active substances, the chewing gum base being present in a particle size of 0.2 to 1 mm, together with the fillers, additives and active substances, in the matrix of fats and waxes. The tablet form is preferably coated with a tablet coating. Production is effected by separately comminuting the chewing gum base on the one hand and the matrix on the other hand at low temperatures, mixing the two types of granules and then pressing the mixture on a cooled tableting press. Finally, the tablets are coated with a covering layer and slowly heated to 40 DEG -45 DEG  C.
Patent JP-3456707-B2 (JP)
IPC: C22C38/00
Filed: 1997-06-16
Granted: 2003-10-14
Abstract: A powder metallurgically produced hot work steel has the composition (by wt.) 0.25-0.45% C, 2.40-4.25% Cr, 2.50-4.40% Mo, 0.20-0.95% V, 2.10-3.90% Co, 0.10-0.80% Si, 0.15-0.65% Mn, balance Fe and impurities. Preferably, the steel has a purity K1 of less than 10 mu m. Also claimed is powder metallurgical production of the above hot work steel by (a) atomising a steel melt of the above composition in a high purity nitrogen atmosphere; (b) filling the resulting powder into capsules designed such that the final product achieves its intended shape with maximum material yield; (c) shaking the filled capsules to achieve maximum filling density; (d) evacuating and then gas-tightly sealing the capsules; and (e) hot isostatically pressing the capsules at 1000-1230 degrees C and 0.8-3.5 (preferably 1) kbar pressure for ≥ 3 hrs.
Patent JP-4173549-B2 (JP)
IPC: C12N5/10
Filed: 1997-06-18
Granted: 2008-10-29
Abstract: A new fibrinogen binding protein or polypeptide originating from coagulase negative staphylococci, biotechnological methods for producing the protein or polypeptide having fibrinogen binding activity and a recombinant DNA molecule coding for the protein (or fragments thereof), and micro-organisms (including viruses) containing this recombinant DNA molecule. The present invention further comprises the therapeutic and diagnostic use of the protein and/or DNA, e.g., a diagnostic kit for determining the presence and/or type of coagulase negative staphylococci and a vaccine composition, comprising the protein or DNA.
Patent JP-H0647505-B2 (JP)
IPC: C04B35/80
Filed: 1988-08-08
Abstract: A method of manufacturing a shaped ceramic article by hot isostatic pressing comprising the following steps: (a) forming a compact of sinterable ceramic compositions, (b) applying a coating to the compact by vapor deposition of a ceramic composition that does not become vitreous before or during the subsequent isostatic pressing step, and (c) heating and isostatically pressing the coated compacts in an atmosphere that reacts with the coating and/or the compact at pressing temperatures and pressures to cause the compact to approach theoretical density. The method is suitable for forming a fired ceramic compact having a whisker loading in excess of about 12.5 volume percent with substantially isotropic properties due to a substantially random orientation of the whiskers.
Patent JP-3072853-B2 (JP)
IPC: C12N15/55
Filed: 1991-06-04
Granted: 2000-08-07
Abstract: This invention relates to lipase containing pharmaceutical compositions comprising a microbial, 1, 3-position specific, crystalline lipase and to methods for treatment or prophylaxis of lipase deficiency in mammals.
Patent JP-2904579-B2 (JP)
IPC: G07D5/08
Filed: 1990-08-09
Granted: 1999-06-14
Abstract: PCT No. PCT/GB90/01245 Sec. 371 Date Feb. 18, 1992 Sec. 102(e) Date Feb. 18, 1992 PCT Filed Aug. 9, 1990 PCT Pub. No. WO91/03032 PCT Pub. Date Mar. 7, 1991.A coin testing apparatus is provided in which two oscillating magnetic fields interact with a coin and these interactions are monitored to test for the acceptability and/or the presence of a coin. The fields are associated with respective inductive coils which have a common core so arranged that not more than a minor proportion of the field of one coil interacts with the other coil. In a preferred embodiment one of the two coils encircles the other, which provides a very compact two-field coin sensing arrangement. In some embodiments one coil encircles the other but they have respective core elements.
Patent JP-4350800-B2 (JP)
IPC: C12N15/86
Filed: 1997-09-24
Granted: 2009-10-21
Abstract: Packaging cell line (A) which expresses one or more adenoviral (Ad) structural proteins (ASPs), polypeptides or fragments selected from: (a) a penton base; (b) a hexon; (c) a fibre; (d) polypeptide IIIa; (e) polypeptide V; (f) polypeptide VI; (g) polypeptide VII; (h) polypeptide VIII, and (i) biologically active fragments. Also claimed are: (1) a viral vector (B) comprising deletion or mutation of a DNA sequence encoding an ASP, polypeptide or fragment selected from (a)-(i) as in (A); (2) a viral vector lacking all or part of a DNA sequence encoding adenovirus fibre protein (AFP) where the DNA sequence has been replaced by a foreign DNA sequence encoding a therapeutic molecule; (3) a viral vector having a mutation in a DNA sequence encoding AFP; (4) a complementing plasmid comprising a promoter nucleotide sequence (NS) operatively linked to a NS encoding an ASP, polypeptide or fragment; (5) a complementing plasmid comprising a promoter NS operatively linked to a NS encoding an Ad regulatory protein (ARP), polypeptide or fragment; (6) a composition useful in the preparation of a therapeutic viral vector, the composition comprising a cell containing a delivery plasmid comprising an Ad genome lacking a NS encoding fibre, and (7) a composition useful in the preparation of therapeutic viral vectors comprising a cell containing: (a) a first delivery plasmid comprising an Ad genome lacking a NS encoding fibre and incapable or directing the packaging of new viral particles in the absence of a second delivery plasmid,and (b) a second delivery plasmid comprising an Ad genome capable of directing the packaging of new viral particles in the presence of the first delivery plasmid.
Patent JP-3611853-B2 (JP)
IPC: B23B27/14
Filed: 1994-02-04
Granted: 2005-01-19
Abstract: Cemented carbide inserts are available containing WC and cubic phases of carbide and/or carbonitride in a binder phase based on cobalt and/or nickel with a binder phase enriched surface zone. The binder phase content along a line essentially bisecting the rounded edge surfaces increases toward the edge and cubic phase is present. As a result, the edge toughness of the cutting inserts is improved.
Patent JP-3860608-B2 (JP)
IPC: A61K38/02
Filed: 1996-02-15
Granted: 2006-12-20
Abstract: A modulator of regulatory cellular events occurring intracellularly which are mediated by regulatory proteins containing a "death domain" motif is provided. The "death domain" is a regulatory portion of the regulatory proteins, and the modulator is capable of interacting with one or more "death domain" motifs contained in the regulatory proteins and affecting the regulatory action of one or more of the regulatory proteins. The modulator preferably is capable of interacting with "death domain" motifs with p55-TNF-R, FAS/APO1-R, NGF-R, MORT-1, RIP, TRADD, or ankyrin, as illustrated in the Figure. A method for producing the modulators is also provided. The modulators are useful for modulating functions mediated in cells by proteins containing the "death domain".
Patent JP-3112946-B2 (JP)
IPC: A61K8/92
Filed: 1995-04-25
Granted: 2000-11-27
Abstract: The subject invention relates to antiperspirant gel compositions comprising chelators. The subject invention also relates to a process for the manufacture of antiperspirant gel compositions comprising the steps of: (a) pre-mixing a chelator with an antiperspirant active in a substantially water free environment; and (b) adding a gelling agent and a liquid base material to the product of step (a) in a substantially water free environment.
Patent JP-3793236-B2 (JP)
IPC: A01C1/02
Filed: 1997-04-28
Granted: 2006-07-05
Abstract: PCT No. PCT/NL97/00230 Sec. 371 Date Jan. 8, 1999 Sec. 102(e) Date Jan. 8, 1999 PCT Filed Apr. 28, 1997 PCT Pub. No. WO97/42489 PCT Pub. Date Nov. 13, 1997The invention is related to a method and an apparatus for sorting seeds for the assessment of the maturity and quality of seeds by measuring the amount of chlorophyll fluorescence. Fluorescence of the chlorophyll molecule is induced by irradiating the seeds with electromagnetic radiation with a suitable wavelength and measuring the chlorophyll fluorescence. Properties of the method are the very high sensitivity, being fully non-destructive and the very high speed.
Patent JP-4647726-B2 (JP)
IPC: C07D233/84
Filed: 1998-03-25
Granted: 2011-03-09
Abstract: The invention relates to a novel anilide compound and a pharmaceutical composition comprising the same. The invention relates to a compound represented by the following general formula: <CHEM> represents a divalent residue of benzene with a substituent(s), heterocycle-condensed benzene which may or may not have a substituent, pyridine which may or may not have a substituent, cyclohexane or naphthalene  or <CHEM>     Ar represents an aryl group which may or may not have a substituent;     X represents -NH-, oxygen atom or sulfur atom; Y represents -NR4-, oxygen atom, sulfur atom, sulfoxide or sulfone;    Z represents single bond or -NR5-; R4 represents hydrogen atom, a lower alkyl group, an aryl group or a silylated lower alkyl group which may or may not have a substituent; R5 represents hydrogen atom, a lower alkyl group, an aryl group or a silylated lower alkyl group which may or may not have a substituent; and   n represents an integer of 0 to 15.   The inventive compounds are useful in the form of pharmaceutical composition, specifically as acyl coenzyme A cholesterol acyltransferase (ACAT) inhibitor.
Patent ES-2489965-B2 (ES)
Title: Sistema compacto de medición óptica con placa discretizada
Inventor: PRUNERI VALERIO
IPC: G01N21/41
Filed: 2013-02-27
Granted: 2015-05-22
Abstract: Sistema compacto de medición óptica con placa discretizada.#La invención se refiere a un sistema compacto para mediciones ópticas que comprende: una fuente de luz y una matriz de detección, medios para conformar el haz de luz procedente de la fuente sobre una placa entre la fuente y la matriz de detección, comprendiendo la placa una superficie discretizada dividida espacialmente en una pluralidad de regiones (R)que comprenden un elemento de forma geométrica, en la que cada región cumple la condición 2zsen{sup,-1}({la}/S) < d en la que z es la distancia entre el detector y la placa, d es el paso entre elementos, {la} es la longitud de onda de la luz procedente de la fuente, S es la longitud del lado menor de un elemento y en la que el área A de cada elemento dentro de la región varía desde 1 {mi}m{sup,2} hasta 10.000 {mi}m{sup,2}, y medios para procesar las señales en la matriz de detección y extraer la información de la fase. La invención puede ser usada fuentes coherentes y parcialmente coherentes, siendo por tanto más económica, más compacta y sin necesidad de técnicas de multiplexado optomecánico para la adquisición de los datos.
Patent ES-2609992-B2 (ES)
Title: Unión para bandejas portacables
Inventor: BANULS TOBARUELA JAVIER
IPC: H02G3/06
Filed: 2015-10-22
Granted: 2017-09-27
Abstract: Unión para bandejas portacables, estando la bandeja formada por una chapa doblada sensiblemente en forma de "U" que presenta una base y dos paredes laterales provistas de un bordón, que incluye un tramo macho con una sección transversal de menores dimensiones que el resto de la chapa, estando el tramo macho exento del bordón y siendo acoplable en un extremo opuesto de una chapa adyacente, tal que en una condición de acoplamiento de dos bandejas adyacentes, las paredes laterales y la base de las bandejas quedan solapadas, estando el tramo macho ubicado por el interior de la chapa adyacente de forma coplanaria. La unión comprende al menos una pieza de unión formada por un cuerpo plegado que define dos aletas en forma de "L", presentando cada aleta una pestaña acoplable en orificios presentes en el tramo macho, teniendo la aleta de la pieza de unión que está vinculada a la pared lateral de la bandeja unos medios de acoplamiento previstos para acoplarse a la pared lateral de la bandeja.
Patent AU-2001239463-B2 (AU)
Title: Combined foam and inflatable collar assemblies for watercraft
Inventor: DALE GARY
IPC: B63B59/02
Filed: 2001-03-02
Granted: 2004-04-22
Abstract: Alternative collar assemblies for use with watercraft including rigid-hulled boats are described. The collars may include both foam materials and one or more inflatable compartments, thereby offering multiple advantages over existing foam or inflatable collars. Optionally included in or on the collars are reinforcing material (such as but not limited to Kevlar) and an abrasion-resistant coating surrounding the foam and inflatable compartments.